electroCore, Inc.

ECOR Healthcare Medical Devices

electroCore, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 27.2% from fiscal 2024. In the quarter to June 2026, revenue grew 28.0%, EPS grew 25.0% and free cash flow fell 443.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

7.85 0.50 −5.99%
Market cap
$75.3M
P/E
0.0×
Fwd P/E
−5.8×
Dividend yield
—
F-score
3/9
Altman Z
−13.54
Beneish M
−4.52
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 3 4 6 4 4 6 3
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — 12.93 (4.27) (1.86) (1.23) (8.87) (14.58) (6.79) (13.54)
P/S ratio
0.00 0.00 184.57 19.55 17.41 6.33 2.20 2.05 4.82 1.19
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(729.23) (6.24) 8.67 (10.72) (9.20) (1.47) (19.40) (38.07) (29.29) (36.67)
Beneish M-Score
— (1.34) 0.67 14.39 (3.93) (2.51) (3.70) (3.21) (2.44) (4.52)
P/Operating CF
0.00 0.00 (15.05) (5.13) (17.00) (7.93) (4.70) (10.54) (96.65) (24.73)
P/B ratio
0.00 0.00 2.77 1.88 2.57 0.94 1.10 4.42 16.08 0.00
Price to Tangible BV
0.00 0.00 2.77 1.88 2.57 0.94 1.10 4.42 16.08 0.00
EV/Sales
0.00 0.00 119.69 10.33 11.54 0.11 0.19 1.43 4.36 1.04
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(0.11) (0.11) (2.52) (0.55) (2.01) (0.04) (0.10) (1.57) (15.79) (4.05)
EV/FCF
(0.11) (0.11) (2.51) (0.55) (2.01) (0.04) (0.10) (1.55) (15.34) (4.02)
Quick Ratio
0.11 6.09 9.73 2.69 3.89 6.40 2.61 1.39 1.48 1.11
Current Ratio
0.12 6.38 10.28 2.90 4.26 6.84 3.01 1.76 1.78 1.38
Net Debt/EBITDA
(0.26) 1.79 1.25 0.49 0.89 1.74 0.78 0.58 1.07 0.40
Debt/Assets
666.66% 5.71% 0.00% 4.00% 3.48% 1.63% 2.52% 0.00% 0.00% 35.39%
Debt/Equity
(0.55) 0.07 0.00 0.06 0.05 0.02 0.04 0.00 0.00 (3.87)
Asset Turnover
0.01 0.04 0.02 0.04 0.10 0.15 0.25 0.78 1.38 1.64
Operating CF/Net income
0.84 0.00 1.36 1.00 0.85 0.79 0.75 0.78 0.58 0.59
Capex/Depreciation
0.00 (0.02) 0.65 0.25 0.00 0.00 0.00 (0.21) 0.00 (0.10)
Interest Coverage
(64.04) (4.07) (54.21) (47.48) (266.97) (1,873.18) (79.70) — (31.26) (22.29)
ROE
20.83% 0.00% 298.10% (99.14%) (96.87%) (57.11%) (82.49%) (153.57%) (158.63%) (478.70%)
ROA
(78.97%) 0.00% (61.56%) (82.87%) (70.20%) (46.32%) (65.58%) (92.19%) (65.00%) (71.37%)
ROIC
0.00% 0.00% 0.00% (1,275.76%) (731.55%) (471.20%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
439.47% 0.00% (52.57%) (254.59%) (121.08%) (53.47%) (156.31%) (295.44%) (162.69%) (297.15%)
Average Days of Receivables
35.48 46.42 98.36 75.75 28.24 29.33 17.04 16.33 19.81 11.70
Research and Development Expense of Revenue
3,137.07% 964.99% 1,255.41% 414.27% 120.18% 46.52% 64.25% 33.19% 9.37% 8.54%
Selling, General and Administrative Expense of Revenue
2,821.45% 2,231.26% 4,280.12% 1,481.92% 624.78% 395.76% 283.17% 169.52% 123.89% 119.27%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
56.12% 56.97% 765.31% 162.98% 97.91% 60.41% 31.22% 10.59% 7.43% 6.03%
Graham Net Nets
0.00 0.00 0.36 0.34 0.28 0.91 0.72 0.17 0.03 (0.12)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.73
Earnings Yield
(9.22%) (9.22%) (18.85%) (96.18%) (41.01%) (51.40%) (120.76%) (59.63%) (9.99%) (36.75%)
Free Cash Flow Yield
0.00% 0.00% (25.86%) (96.58%) (33.06%) (39.68%) (88.58%) (45.17%) (5.90%) (21.67%)
Revenue per Share
0.03 0.00 0.51 1.22 1.34 1.38 1.82 2.91 3.37 3.78
Operating CF per Share
(1.32) 0.00 (24.14) (23.00) (7.71) (3.45) (3.52) (2.66) (0.93) (0.97)
Capex per Share
0.00 0.00 (0.14) (0.04) 0.00 0.00 0.00 (0.04) 0.00 (0.01)
Free Cash Flow per Share
(1.32) 0.00 (24.28) (23.03) (7.71) (3.45) (3.52) (2.70) (0.93) (0.97)
Cash per Share
0.04 0.00 35.13 12.28 8.70 8.79 3.80 1.92 1.63 1.37
Shareholders Equity per Share
(0.75) 0.00 33.91 12.71 9.09 9.29 3.61 1.35 1.01 (0.20)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.75) 0.00 33.91 12.71 9.09 9.29 3.61 1.35 1.01 (0.20)
Free Cash Flow
(13.23) (25.48) (47.39) (45.14) (20.05) (13.63) (16.64) (14.87) (6.95) (8.25)
Working Capital
(3.63) 32.91 65.63 17.39 19.17 32.06 14.13 6.17 7.15 4.32
Capital Expenditures
— (0.15) (0.28) (0.07) — — — (0.21) — (0.07)
Net Current Asset Value
(7.65) 32.61 65.38 15.97 17.19 31.36 13.50 5.63 3.37 (4.71)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.19 0.28 0.03 0.00 0.00 0.00 0.01 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
12.20 36.25 (1.13) (0.81) 1.76 3.56 10.96 4.72 4.81 1.66
Cash ROIC
445.00% (35.28%) (35.17%) (89.60%) (42.33%) (18.92%) (46.66%) (82.53%) (35.16%) (49.99%)
Accounts Receivable Turnover
3.97 12.69 5.36 6.26 9.12 15.39 20.48 28.68 24.17 26.76
Accounts Payable Turnover
0.06 0.25 0.33 0.29 0.48 0.92 1.05 1.31 1.90 1.87
Inventory Turnover
0.66 2.76 0.51 0.81 1.97 1.24 0.97 1.35 1.97 2.57
Average Days of Payables
9,726.94 591.60 1,702.26 1,643.29 436.68 247.20 480.87 281.56 176.18 233.24
Days of Inventory on Hand
143.11 230.76 1,229.53 281.08 184.11 358.68 447.67 281.17 161.62 140.27
Average Receivables
0.06 0.06 0.19 0.38 0.38 0.35 0.42 0.56 1.04 1.20
Average Payables
2.07 2.07 1.77 3.95 3.64 1.51 1.53 2.15 2.00 2.27
Average Inventory
0.19 0.19 1.14 1.42 0.88 1.12 1.67 2.07 1.92 1.65
Average Assets
19.93 19.93 56.37 54.48 33.49 37.18 33.79 20.43 18.29 19.57
Average Common Equity
(75.56) (75.26) (11.64) 45.54 24.27 30.15 26.87 12.26 7.49 2.92

Fold the line items

Columns are period end dates